Century Therapeutics
IPSC
72 hedge funds and large institutions have $312M invested in Century Therapeutics in 2026 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 6 closing their positions.
2,475% more call options, than puts
Call options by funds: $103K | Put options by funds: $4K
1,122% more capital invested
Capital invested by funds: $25.6M → $312M (+$287M)
433% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 6
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
53% more funds holding
Funds holding: 47 → 72 (+25)
47.79% more ownership
Funds ownership: 29.42% → 77.2% (+48%)
45% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$37.3M |
| 2 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$37.3M |
| 3 |
VVM
Versant Venture Management
San Francisco,
California
|
+$25.6M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$19.9M |
| 5 |
CC
Commodore Capital
New York
|
+$18.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.97M |
| 2 |
Renaissance Technologies
New York
|
-$930K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$755K |
| 4 |
SCM
Superstring Capital Management
New York
|
-$723K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$672K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Jane Street
New York
| – | -$95K | -45,194 | Closed |
|
|
SRL
77
Scientech Research LLC
Jersey City,
New Jersey
| – | -$12.3K | -12,355 | Closed |
|
78
Citigroup
New York
| – | -$1 | -1 | Closed |
|
IPSC Hedge Fund Activity: Q1 2026 in Review
72 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q1 2026, worth a combined $312M — up 1,122% from $25.6M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new IPSC positions and 6 closed out — a net gain of 26 holders — while 16 added to existing stakes and 11 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $37.3M. The largest seller was Acadian Asset Management, cutting an estimated $1.97M.
- 72 institutional investors held Century Therapeutics (IPSC) as of Q1 2026, up from 47 in Q4 2025.
- Funds reported $312M of Century Therapeutics stock for Q1 2026, up 1,122% quarter-over-quarter.
- 32 funds opened new Century Therapeutics positions in Q1 2026 and 6 closed out, a net change of +26 holders.
- The largest Century Therapeutics buyer in Q1 2026 was RA Capital Management, an estimated $37.3M added.
- The largest Century Therapeutics seller in Q1 2026 was Acadian Asset Management, an estimated $1.97M sold.
Based on aggregated 13F filings for Q1 2026.